Legacy Capital Wealth Partners LLC acquired a new stake in shares of Danaher Co. (NYSE:DHR – Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 893 shares of the conglomerate’s stock, valued at approximately $223,000.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in DHR. Norges Bank purchased a new position in shares of Danaher in the 4th quarter worth approximately $1,752,382,000. Vanguard Group Inc. increased its position in shares of Danaher by 7.4% during the first quarter. Vanguard Group Inc. now owns 60,107,030 shares of the conglomerate’s stock worth $15,009,928,000 after purchasing an additional 4,163,657 shares in the last quarter. Wellington Management Group LLP lifted its holdings in shares of Danaher by 12.0% during the 4th quarter. Wellington Management Group LLP now owns 27,928,442 shares of the conglomerate’s stock valued at $6,460,966,000 after purchasing an additional 2,998,161 shares during the last quarter. Swedbank AB acquired a new stake in shares of Danaher in the 1st quarter worth $676,545,000. Finally, DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main grew its stake in Danaher by 214.4% during the 4th quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 3,073,661 shares of the conglomerate’s stock worth $711,051,000 after buying an additional 2,096,038 shares during the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.
Insider Activity at Danaher
In other Danaher news, CEO Rainer Blair sold 9,007 shares of the company’s stock in a transaction dated Wednesday, July 31st. The shares were sold at an average price of $280.00, for a total value of $2,521,960.00. Following the completion of the transaction, the chief executive officer now owns 97,983 shares in the company, valued at $27,435,240. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. In other news, CEO Rainer Blair sold 9,007 shares of the business’s stock in a transaction that occurred on Wednesday, July 31st. The stock was sold at an average price of $280.00, for a total value of $2,521,960.00. Following the completion of the sale, the chief executive officer now directly owns 97,983 shares in the company, valued at $27,435,240. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Georgeann Couchara sold 952 shares of the company’s stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $268.37, for a total value of $255,488.24. Following the transaction, the senior vice president now directly owns 4,212 shares of the company’s stock, valued at $1,130,374.44. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 39,659 shares of company stock worth $11,042,433. 11.10% of the stock is owned by company insiders.
Wall Street Analyst Weigh In
Check Out Our Latest Report on DHR
Danaher Stock Performance
Shares of DHR stock opened at $264.49 on Thursday. Danaher Co. has a 52-week low of $182.09 and a 52-week high of $281.70. The company has a quick ratio of 1.04, a current ratio of 1.43 and a debt-to-equity ratio of 0.33. The stock has a market cap of $195.90 billion, a PE ratio of 44.83, a price-to-earnings-growth ratio of 4.43 and a beta of 0.83. The business has a 50-day simple moving average of $260.72 and a 200-day simple moving average of $255.55.
Danaher (NYSE:DHR – Get Free Report) last released its quarterly earnings data on Tuesday, July 23rd. The conglomerate reported $1.72 EPS for the quarter, topping the consensus estimate of $1.57 by $0.15. Danaher had a return on equity of 11.06% and a net margin of 16.94%. The business had revenue of $5.74 billion for the quarter, compared to analyst estimates of $5.59 billion. During the same quarter in the prior year, the firm posted $2.05 EPS. The business’s quarterly revenue was down 2.9% compared to the same quarter last year. On average, equities analysts expect that Danaher Co. will post 7.59 EPS for the current year.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Recommended Stories
- Five stocks we like better than Danaher
- What Makes a Stock a Good Dividend Stock?
- Why Dick’s Could Be a Slam Dunk for Your Investment Portfolio
- Bank Stocks – Best Bank Stocks to Invest In
- Introduction to Fibonacci Retracement Levels
- Stock Dividend Cuts Happen Are You Ready?
- Top 3 Stocks to Outperform the S&P 500 in a Downturn
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.